Accessibility Menu
 

ContraFect

(OTC) CFRXQ

Current Price$0.00
Market CapN/A
Since IPO (2014)-100%
5 Year-100%
1 Year-99%
1 Month+0%

ContraFect Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$24.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-81.44 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CFRXQ News

No articles available.

CFRXQ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ContraFect

Industry

Biotechnology

Employees

23

CEO

Roger J. Pomerantz, MD

Headquarters

Yonkers, NY 10701, US

CFRXQ Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

353%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

10.70M

Volume

1

Short Interest

0.00%

Avg. Volume

428.433

Financials (TTM)

Gross Profit

$154.00K

Operating Income

$56.89M

EBITDA

$65.00M

Operating Cash Flow

$45.97M

Capital Expenditure

$62.00K

Free Cash Flow

$46.04M

Cash & ST Invst.

$13.68M

Total Debt

$2.88M

ContraFect Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$39.00K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

23

N/A

Net Income

$5.36M

+68.6%

EBITDA

$6.64M

+53.1%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$2.86M

-80.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.87M

-19.0%

Short Term Debt

$680.00K

+1.9%

Return on Assets

-3.15%

N/A

Return on Invested Capital

353.35%

N/A

Free Cash Flow

$8.67M

+10.4%

Operating Cash Flow

$8.67M

+10.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMVIFIMV Inc.
$0.00+0.00%
EFTReFFECTOR Therapeutics, Inc.
$0.00+0.00%
OMMHOmnimmune Holdings, Inc.
$0.00+0.00%
ADYXAdynxx, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About CFRXQ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.